Constant Vigilance Against Dangerous Air Intrusion
Visually inspecting lines and manually removing air is the current standard of care for removing an air mass in IV lines, resulting in inconsistent monitoring and avoidable, adverse outcomes. ClearLine IV detects air masses as small as 25 microliters, which is 50% smaller than today’s technology. This easy-to-use, hands-free device significantly reduces the potential for human error when inspecting lines. It works with all pumps, warmers and IV bag sets to deliver fluid safely to the patient.
According to the Centers for Medicare and Medicaid Services (CMS) and the American Academy of Orthopaedic Surgeons (AAOS), air embolisms are the second most common serious, preventable, adverse event.1 An air mass can enter the body through a vein and travel quickly to the brain, heart or lungs.
Some complications include:
Air embolism treatment costs range from $8,000-$12,000 per case. This avoidable problem also may result in large settlement payout costs for hospital administration. A FDA total product life cycle report on infusion pumps2 showed that 3% of issues were caused by air embolisms with a 30% mortality rate.
Case law data according to a Frenkel + Company report3 on air embolism settlement and jury verdict values:
|Maine||3-day-old infant||Brain damage, cerebral palsy and quadriplegia||$2.5M to the family because air was not removed from the IV line during intestinal surgery|
|Wisconsin||Male infant||Brain damage||$2.3M to the family for an air mass in an IV line during a blood transfusion|
|Washington||1-day-old infant||Death||$750,000 to the family because a doctor allowed an air embolism during a blood transfusion|
2 Chubb internal reporting
3 Frankel + Company internal reporting